For over 10 years now TriLink has offered cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the modification of oligonucleotides and nucleoside triphosphates. We provide a wide range of services from radioactive labeling to conjugation to custom research. With a proven track record of manufacturing challenging novel oligonucleotides and nucleotides, high-purity compounds and excellent technical support are the hallmarks of TriLink.

TriLink’s founders have been on the forefront of the advancements in oligonucleotide synthesis. Our scientists and technicians have decades of collective experience in synthesizing modified nucleosides, nucleotides and oligonucleotides for research, diagnostics and pre-clinical therapeutic applications. TriLink’s facility features a 10,000 square foot laboratory with a QSR environment for production of oligos and small molecules. We also offer radiolabeling services for pharmacokinetic studies, custom chemistry and contract research services.

TriLink offers:

• Milligram to multigram capacity
• Affordable, no-obligation oligo production following the FDA’s Quality System Regulations (QSR)
• Industry-leading expertise and technical support
• World-class proficiency in making highly-modified oligonucleotides
• Oligonucleotide radiolabeling services